Article
Update on new pulmonary therapies.
Current opinion in pulmonary medicine - 1 Nov 2009
Retsch-Bogart George Z
Abstract excerpt
PURPOSE OF REVIEW: Understanding the molecular and cellular processes responsible for the development of lung disease in cystic fibrosis (CF) has led to evaluation of a broad range of new therapies within multiple therapeutic classes. For these reasons, clinical research in CF is accelerating, as new agents progress through the early stages of drug development, move into clinical trials and are offered to study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
